Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Armand received his MD and PhD from the University of California, San Francisco in 2000. He completed his postgraduate training at Brigham and Women's Hospital and at Dana-Farber Cancer Institute in Boston. In 2007, he joined DFCI and is a member of the Hematologic Malignancies staff.
Dr. Armand leads the Lymphoma Division at Dana-Farber Cancer Institute. He oversees a diverse portfolio of clinical research across different lymphoma subtypes and types of therapy. Current areas of high priority include:
Across these areas, the driving principle of research in the Division is to apply cutting-edge scientific understanding of lymphoma to support the development of clinical trials testing novel therapeutic approaches; while in turn using data and samples from these trials to support laboratory research, advance the scientific understanding and inform the next generation of studies.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions